HUMA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HUMA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Humacyte's purchase of property, plant, equipment for the three months ended in Sep. 2024 was $-0.93 Mil. It means Humacyte spent $0.93 Mil on purchasing property, plant, equipment. Humacyte's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Sep. 2024 was $-1.66Mil.
Compared with last quarter ($-0.18 Mil in Jun. 2024 ), Humacyte spent more money on purchasing property, plant, equipment in Sep. 2024 ($-0.93 Mil).
The historical data trend for Humacyte's Purchase Of Property, Plant, Equipment can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Humacyte Annual Data | |||||||||
Trend | Dec20 | Dec21 | Dec22 | Dec23 | |||||
Purchase Of Property, Plant, Equipment | -0.32 | -0.22 | -1.05 | -2.28 |
Humacyte Quarterly Data | |||||||||||||||||
Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Purchase Of Property, Plant, Equipment | Get a 7-Day Free Trial | -0.49 | -0.15 | -0.39 | -0.18 | -0.93 |
The amount used to purchase PPE.
Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.66 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Humacyte's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.
Michael T. Constantino | director | C/O 9 METERS BIOPHARMA, INC., 8480 HONEYCUTT ROAD, SUITE 120, RALEIGH NC 27615 |
Laura E Niklason | director, 10 percent owner, officer: President, CEO and Director | 35 WILSHIRE ROAD, GREENWICH CT 06831 |
Brady W Dougan | director, 10 percent owner | 35 WILSHIRE ROAD, GREENWICH CT 06831 |
Kathleen Sebelius | director | C/O DERMIRA, INC., 275 MIDDLEFIELD ROAD, SUITE 150, MENLO PARK CA 94025 |
Dale A. Sander | officer: CFO & CCDO | 11304 EMPIRE LAKES DRIVE, RALEIGH NC 27617 |
Heather Ledbetter Prichard | officer: Chief Operating Officer | 820 BROWNWICH STREET, WAKE FOREST NC 27587 |
Max N. Wallace | director | 210 WEST TRYON STREET, HILLSBOROUGH NC 27278 |
Gordon M Binder | director | 225 S. LAKE AVE., SUITE 300, PASADENA CA 91101 |
Ayabudge Llc | 10 percent owner | 35 WILSHIRE ROAD, GREENWICH CT 06831 |
William John Scheessele | officer: Chief Commercial Officer | 620 WADE AVENUE, UNIT 501, RALEIGH NC 27605 |
Yang Cao | officer: Chief Regulatory Officer | 12 DOGLEG LANE, LAWRENCE NJ 08648 |
Charles Bruce Green | director | 3185 SCENIC DRIVE, NAPA CA 94558 |
Diane Seimetz | director | JUTASTRASSE, MUNICH 2M 80636 |
Shamik J Parikh | officer: Chief Medical Officer | 1160 HEDGEROW DRIVE, GARNET VALLEY PA 19060 |
Rajiv Shukla | director | EMERALD VIEW SUITE 400, 2054 VISTA PARKWAY, WEST PALM BEACH FL 33411 |
From GuruFocus
By PRNewswire • 12-02-2024
By PRNewswire • 12-05-2024
By Marketwired • 12-02-2024
By Marketwired • 12-05-2024
By GuruFocus News • 12-05-2024
By PRNewswire • 12-06-2024
By PRNewswire • 12-02-2024
By Marketwired • 12-02-2024
By PRNewswire • 12-05-2024
By Marketwired • 12-03-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.